XML 52 R32.htm IDEA: XBRL DOCUMENT
v3.22.1

Shareholders' Equity (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2021
Shareholders' Equity (Tables) [Line Items] |
Schedule of issued and outstanding |
|  |  | December 31, 2021 |  |  | December 31, 2020 |
|  |  | Authorized |  |  | Issued and Outstanding |  |  | Authorized |  |  | Issued and Outstanding |
Ordinary shares |  |  |  | 100,000,000 |  |  |  | 51,791,441 |  |  |  | 100,000,000 |  |  |  | 46,100,173 |
Total |  |  |  | 100,000,000 |  |  |  | 51,791,441 |  |  |  | 100,000,000 |  |  |  | 46,100,173 |
Schedule of share-based awards to employees, officers and directors |
|  | Year ended December 31, |  |  | Year ended December 31, |
|  | 2021 |  |  | 2020 |
|  | Number of |  |  | Weighted |  |  | Number of |  |  | Weighted |
|  | share-based |  |  | average |  |  | share-based |  |  | average |
|  | payment |  |  | exercise |  |  | payment |  |  | exercise |
|  | awards |  |  | price |  |  | awards |  |  | price |
Outstanding at beginning of year |  |  | 3,372,626 |  |  | $ | 5.27 |  |  |  | 3,410,406 |  |  | $ | 1.89 |
Changes during the year: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Granted |  |  | 180,319 |  |  |  | 40.12 |  |  |  | 1,327,957 |  |  | $ | 13.70 |
Exercised |  |  | (1,043,142 | ) |  |  | 7.66 |  |  |  | *(1,267,012 | ) |  | $ | 8.94 |
Forfeited |  |  | (118,954 | ) |  |  | 10.18 |  |  |  | - |  |  |  | - |
Expired |  |  | (66,606 | ) |  |  | 16.37 |  |  |  | - |  |  |  | - |
Cancelled |  |  | - |  |  |  | - |  |  |  | (98,725 | ) |  |  | 1.92 |
Outstanding at end of year |  |  | 2,324,243 |  |  |  | 6.17 |  |  |  | 3,372,626 |  |  | $ | 5.27 |
Exercisable at end of year |  |  | 1,618,777 |  |  |  | 3.35 |  |  |  | 2,191,042 |  |  | $ | 5.67 |
Schedule of Black-Scholes option-pricing model |
|  | Year ended December 31, 2021 |  |  | Year ended December 31, 2020 |
Dividend yield |  | 0 |  |  | 0 |
Expected volatility |  | 50.27% - 52.71% |  |  | 57.34%-44.40% |
Risk-free interest rate |  | 0.66% - 1.61% |  |  | 0.27%-1.61% |
Contractual term (years) |  | 0–10 |  |  | 5–10 |
|  | 2021 |  |  | 2020 |
Dividend yield |  |  | 0 |  |  |  | 0 |
Expected volatility |  |  | 50.27%-51.84% |  |  |  | 45.11%-55.97% |
Risk-free interest rate |  |  | 0.66%-1.61% |  |  |  | 0.23%-1.61% |
Contractual term (years) |  |  | 10 |  |  |  | 10 |
Schedule of information concerning outstanding and exercisable awards |
December 31, 2021 |
Awards outstanding |  |  | Awards exercisable |
|  |  | Number of |  |  | Weighted |  |  | Number of |  |  | Weighted |
|  |  | awards |  |  | average |  |  | award |  |  | average |
|  |  | outstanding |  |  | remaining |  |  | exercisable |  |  | remaining |
Exercise |  |  | at end of |  |  | contractual |  |  | at end of |  |  | contractual |
price |  |  | year |  |  | life (years) |  |  | year |  |  | life (years) |
$ | 1.92 |  |  |  | 192,927 |  |  |  | 0.04 |  |  |  | 192,927 |  |  |  | 0.04 |
$ | 2.21 |  |  |  | 1,769,513 |  |  |  | 7.89 |  |  |  | 1,288,236 |  |  |  | 7.89 |
$ | 16.00 |  |  |  | 161,484 |  |  |  | 5.43 |  |  |  | 114,477 |  |  |  | 4.22 |
$ | 23.19 |  |  |  | 21,000 |  |  |  | 9.78 |  |  |  | - |  |  |  | - |
$ | 23.84 |  |  |  | 30,000 |  |  |  | 9.88 |  |  |  | - |  |  |  | - |
$ | 30.93 |  |  |  | 20,000 |  |  |  | 8.81 |  |  |  | 20,000 |  |  |  | 8.81 |
$ | 30.66 |  |  |  | 12,000 |  |  |  | 9.53 |  |  |  | - |  |  |  | - |
$ | 40.21 |  |  |  | 17,319 |  |  |  | 9.19 |  |  |  | 3,137 |  |  |  | 9.19 |
$ | 49.68 |  |  |  | 100,000 |  |  |  | 9.05 |  |  |  | - |  |  |  | - |
December 31, 2020 |
Awards outstanding |  |  | Awards exercisable |
|  |  | Number of |  |  | Weighted |  |  | Number of |  |  | Weighted |
|  |  | awards |  |  | average |  |  | award |  |  | average |
|  |  | outstanding |  |  | remaining |  |  | exercisable |  |  | remaining |
Exercise |  |  | at end of |  |  | contractual |  |  | at end of |  |  | contractual |
price |  |  | year |  |  | life (years) |  |  | year |  |  | life (years) |
$ | 0.01 |  |  |  | 186,815 |  |  |  | 0.33 |  |  |  | 186,815 |  |  |  | 0.33 |
$ | 1.92 |  |  |  | 269,714 |  |  |  | 1.18 |  |  |  | 269,714 |  |  |  | 1.18 |
$ | 2.21 |  |  |  | 2,191,349 |  |  |  | 6.22 |  |  |  | 1,188,914 |  |  |  | 6.22 |
$ | 16.00 |  |  |  | 444,748 |  |  |  | 8.89 |  |  |  | 283,933 |  |  |  | 8.89 |
$ | 18.00 |  |  |  | 260,000 |  |  |  | 3.86 |  |  |  | 260,000 |  |  |  | 3.86 |
$ | 30.93 |  |  |  | 20,000 |  |  |  | 9.81 |  |  |  | 1,666 |  |  |  | 9.81 |
December 31, 2021 |
Awards outstanding |  |  | Awards exercisable |
|  |  | Number of |  |  | Weighted |  |  | Number of |  |  | Weighted |
|  |  | awards |  |  | average |  |  | awards |  |  | average |
|  |  | outstanding |  |  | remaining |  |  | exercisable |  |  | remaining |
Exercise |  |  | at end of |  |  | contractual |  |  | at end of |  |  | contractual |
price |  |  | year |  |  | life (years) |  |  | year |  |  | life (years) |
| $0.00-0.01 |  |  |  | 120,757*) |  |  |  | - |  |  |  | 73,679 |  |  |  | - |
| $2.21 |  |  |  | 1,130,143 |  |  |  | 7.95 |  |  |  | 716,448 |  |  |  | 7.95 |
| $16.00 |  |  |  | 88,500 |  |  |  | 7.48 |  |  |  | 35,791 |  |  |  | 6.09 |
| $17.63-$64.61 |  |  |  | 1,421,530 |  |  |  | 9.68 |  |  |  | 19,438 |  |  |  | 8.98 |
December 31, 2020 |
Awards outstanding |  |  | Awards exercisable |
|  |  | Number of |  |  | Weighted |  |  | Number of |  |  | Weighted |
|  |  | awards |  |  | average |  |  | awards |  |  | average |
|  |  | outstanding |  |  | remaining |  |  | exercisable |  |  | remaining |
Exercise |  |  | at end of |  |  | contractual |  |  | at end of |  |  | contractual |
price |  |  | year |  |  | life (years) |  |  | year |  |  | life (years) |
| $2.21 |  |  |  | 1,995,625 |  |  |  | 9.05 |  |  |  | 1,019,695 |  |  |  | 9.05 |
| $16.00 |  |  |  | 205,000 |  |  |  | 9.62 |  |  |  | 37,917 |  |  |  | 9.62 |
| $26.56-$59.20 |  |  |  | 180,500 |  |  |  | 9.93 |  |  |  | 4,167 |  |  |  | 9.93 |
Schedule of share-based compensation expenses |
|  | Year Ended December 31, |
|  | 2021 |  |  | 2020 |  |  | 2019 |
|  | (U.S. dollars in thousands) |
Cost of revenue |  |  | 51 |  |  |  | - |  |  |  | - |
Research and development |  |  | 3,248 |  |  |  | 3,384 |  |  |  | 661 |
Sales and Marketing (*) |  |  | 2,442 |  |  |  | 9,252 |  |  |  | 617 |
General and administrative |  |  | 13,065 |  |  |  | 12,145 |  |  |  | 14,967 |
|  |  | 18,806 |  |  |  | 24,781 |  |  |  | 16,245 |
Employees, Officers and Directors [Member] |
Shareholders' Equity (Tables) [Line Items] |
Schedule of issued and outstanding |
|  | Year ended |  |  | Year ended |
|  | December 31, 2021 |  |  | December 31, 2020 |
|  | Number of |  |  | Weighted |  |  | Number of |  |  | Weighted |
|  | share-based |  |  | average |  |  | share-based |  |  | average |
|  | payment awards |  |  | exercise price |  |  | payment awards |  |  | exercise price |
Outstanding at beginning of year |  |  | 2,381,125 |  |  | $ | 4.14 |  |  |  | 1,667,267 |  |  | $ | 2.21 |
Changes during the year: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Granted |  |  | 1,418,665 |  |  | $ | 27.57 |  |  |  | 730,734 |  |  |  | 13.53 |
Issued due to business combination |  |  | 117,536 |  |  |  | 0.00 |  |  |  | - |  |  |  | - |
Exercised |  |  | (837,724 | ) |  |  | 3.11 |  |  |  | - |  |  |  | - |
Forfeited |  |  | (318,672 | ) |  |  | 19.69 |  |  |  | - |  |  |  | - |
Expired |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Cancelled |  |  | - |  |  |  | - |  |  |  | (16,876 | ) |  |  | 2.21 |
Outstanding at end of year |  |  | 2,760,930 |  |  | $ | 15.85 |  |  |  | 2,381,125 |  |  |  | 4.14 |
Exercisable at end of year |  |  | 845,356 |  |  | $ | 3.58 |  |  |  | 1,061,778 |  |  |  | 2.80 |

X
- References No definition available. + Details
Name: | nnox_ScheduleOfIssuedAndOutstandingTextBlock
Namespace Prefix: | nnox_
Data Type: | dtr:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | nnox_ShareholdersEquityTablesLineItems
Namespace Prefix: | nnox_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the change in common stock outstanding. + References No definition available. + Details
Name: | us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for stock awards granted to nonemployee directors that were outstanding at the beginning and end of the year, and the number of awards that were granted, exercised or converted, forfeited, and expired during the year. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (g) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationNonemployeeDirectorStockAwardPlanActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (f)(2) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5047-113901 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 50 -Section S99 -Paragraph 1 -URI https://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775 + Details
Name: | us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | srt_TitleOfIndividualAxis=nnox_EmployeesOfficersAndDirectorsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |